While current medicine is limited by a drive toward short-term profit and human fallacy, the exponential data-analyzing power of AI can be used to more accurately analyze and predict a person’s current health and health trajectory.
TAMPA, Fla. (PRWEB) August 22, 2022
How would healthcare and self-care transform with a more reliable and accurate early detection system? Researchers estimate that 42% of cancer cases and 45% of cancer deaths in the U.S. can be attributed to risk factors that could be modified through lifestyle changes (1). CT scans and early detection tests reduce cancer fatality rates, but many cases are not caught until cancer has spread (2). While up to 80% of heart disease cases are preventable, it remains a top killer and costs the healthcare system more than $1 trillion a year (3).
Even very high-net-worth individuals like Steve Jobs or Bill Gates’ mother, who had access to technology, doctors, and knowledge, did not catch their ultimately terminal disease at an early enough stage to successfully treat it. Enter “stabilizing” disruptor Oleg Teterin, of Longevity InTime, who explains to Karla Jo Helms, host of the Disruption Interruption podcast, that while current medicine is limited by a drive toward short-term profit and human fallacy, the exponential data-analyzing power of AI can be used to more accurately analyze and predict a person’s current health and health trajectory.
At the tender age of 33, Oleg faced a challenging genetic disorder and viscerally realized his inevitable mortality. Realizing the profit-driven medical system could offer only limited help, Oleg said to himself, THAT’S IT — I’M DONE WITH THE STATUS QUO, and formulated a plan to use AI to motivate people to take better care of themselves, help confirm doctor’s diagnosis, and deliver a more customized health assessment than is currently available today for any price.
AI can track 400 different health parameters, while current medical exams track up to about 20.
Each person’s health prognosis is influenced by genetic factors, environmental factors, and lifestyle factors that are challenging for doctors to accurately track but are possible for AI.
The earlier a problem is detected, the easier it is to successfully treat.
Lifetime health tracking is an unprecedented way to stay on top of your risk factors and catch and prevent health issues before they take hold.
The goal of Longevity InTime is to provide the right foresight and information to extend the human lifespan to 95 to 120 years of healthy, happy, functional experience.
Longevity InTime is opening a longevity scientific resort in the Maldives. Healthy people can send tests from their home countries for lifetime health tracking. People who need medical care can access revolutionary, scientifically backed procedures.
The data available for analysis is already vast, but as more individuals participate in lifetime health tracking, the predictive and preventative nature of the data will be unmatched.
Disruption Interruption is the podcast where you’ll hear from today’s biggest Industry Disruptors. Learn what motivated them to bring about change and how they overcome opposition to adoption.
Disruption Interruption can be listened to via the Podbean app and is available on Apple’s App Store and Google Play.
About Disruption Interruption:
Disruption is happening on an unprecedented scale, impacting all manner of industries — MedTech, Finance, IT, eCommerce, shipping and logistics, and more — and COVID has moved their timelines up a full decade or more. But WHO are these disruptors, and when did they say, “THAT’S IT! I’VE HAD IT!”? Time to Disrupt and Interrupt with host Karla Jo “KJ” Helms, veteran communications disruptor.
KJ interviews badasses who are disrupting their industries and altering economic networks that have become antiquated with an establishment resistant to progress. She delves into uncovering secrets from industry rebels and quiet revolutionaries that uncover common traits — and not-so-common — that are changing our economic markets … and lives. Visit the world’s key pioneers that persist to success, despite arrows in their backs, at http://www.disruptioninterruption.com.
About Karla Jo Helms:
Karla Jo Helms is the Chief Evangelist and Anti-PR™ Strategist for JOTO PR Disruptors™.
Karla Jo learned firsthand how unforgiving business can be when millions of dollars are on the line — and how the control of public opinion often determines whether one company is happily chosen or another is brutally rejected.
Being an alumni of crisis management, Karla Jo has worked with litigation attorneys, private investigators, and the media to help restore companies of goodwill back into the good graces of public opinion — Karla Jo operates on the ethic of getting it right the first time, not relying on second chances and doing what it takes to excel. Helms speaks globally on public relations, how the PR industry itself has lost its way, and how, in the right hands, corporations can harness the power of anti-PR to drive markets and impact market perception.
About Longevity InTime:
Longevity InTime develops online diagnosis technology to detect the early stages of diseases and prolong life. The company’s objective is to predict and prevent severe diseases using real-time monitoring of 400+ essential health parameters.
Wan AI server trained on the 50+ years of G20 big data, we make personal recommendations to our users on how to avoid the upcoming diseases and extend their lifespan. Longevity InTime is a global, early-stage company with a remarkable team of experienced bioinformaticians, scientists, IT developers, and top managers with startup experience. We aim to solve the global problem of longevity through the use of IT tech.
1. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68: 31-54.
2. Trinidad, Camille V; Tetlow, Ashley L; Bantis, Leonidas E; Godwin, Andrew K; “Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers”; 2020 Mar;13(3):241-252.; Cancer Prevention Research; pubmed.ncbi.nlm.nih.gov/32132118/
3. American Heart Association; “CDC Prevention Programs”; Last Reviewed: May 18, 2018 heart.org/en/get-involved/advocate/federal-priorities/cdc-prevention-programs